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Abstract
Objective: Adherence problems are a common feature among bipolar patients. A recent study showed
that lithium knowledge was the main difference between adherent and non adherents bipolar patients. The
Lithium Knowledge Test (LKT), a brief questionnaire, was developed as a means of identifying aspects of
patients' practical and pharmacological knowledge which are important if therapy is to be safe and effective.
The original English version is validated in psychiatric population, but a validated Portuguese one is not yet
available.
Methods: One hundred six patients selected were diagnosed with bipolar disorder (I or II) according to
DSM-IV criteria and had to be on lithium treatment for at least one month. The LKT was administered on
only one occasion. We analysed the internal consis tency, concurrent validity, sensitivity and specificity of
the LKT for the detection of the knowledge about lithium treatment of bipolar patients.
Results: The internal consistency, evaluated by Cronbach's alpha was 0.596. The mean of total score LKT
by bipolar patients was 9.0 (SD: 0.75) for men and 8.74 (SD: 0.44) for women. Concurrent validity based
on plasma lithium concentration showed a significant correlation between the total LKT score and plasma
lithium (r = 0,232; p = 0.020). The sensitivity was 84% and specificity was 81%.
Conclusion: LKT is a rapid, reliable instrument which appears to be as effective as a lengthier standard
interview with a lithium clinic doctor, and which has a high level of acceptability to lithium patients. We
found that the psychometric assessment of the Portuguese version of LKT showed good internal
consistency, sensitivity and specificity.
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Background
To date, lithium is probably still the gold standard for the
long term treatment of bipolar disorder, as shown in clas-
sical papers [1], newer studies [2] and a recent and
thoughtful meta analysis [3]. However, a marked gap has
been noted between the efficacy of lithium in clinical tri-
als and its effectiveness in ordinary clinical practice [4,5],
this difference being almost certainly due to poor treat-
ment adherence [4,6,7]. A survey conducted in the United
States showed that the average time of lithium intake was
as start as 76 days [8].
Adherence problems are a common feature among bipo-
lar patients. A recent study showed that lithium knowl-
edge was the main difference between adherent and non-
adherent bipolar patients [9]. Several studies have shown
that psychoeducative interventions are associated with
high adherence rates, stabilization of plasma lithium lev-
els, reduction of the total number of episodes and total
number of patients needing to hospitalization [10-12].
The fact that patients are informed about the disease, the
treatment and the risks of not treating it positively, influ-
ences adherence, because it facilitates their acceptance of
the disease and maintenance therapy [13-15].
The Lithium Knowledge Test (LKT) a brief questionnaire,
was developed as a means of identifying aspects of
patients' practical and pharmacological knowledge which
are important if therapy is to be safe and effective. One
point is scored for each correct answer and one is
deducted for each wrong answer, giving a total Lithium
Knowledge Score. Some incorrect answers, since they con-
stitute potential hazards to patients on lithium, are added
up to give a Lithium Hazard Score (LHS). The original
English version has been validated in psychiatric popula-
tion and has shown good reliability [16].
Methods
2.1. Subjects
The study was conducted in two psychiatric outpatient
services specialized in mood disorders in the city of Porto
Alegre, Brazil. The psychiatric patients selected were diag-
nosed with bipolar disorder, I and II according to DSM-IV
criteria. The study was approved by the Ethics Committees
on Research of the hospital where the research took place,
where the research took place and was carried out in com-
pliance with the Helsinki Declaration.
The patient selection criteria included a well-established
diagnosis, being on lithium treatment for at least one
month, and regularly complying with the weekly visits
scheduled in two psychiatric outpatients who agreed in
take part in the survey.
In the weekly consultations, the patients were evaluated
for both their symptoms and general state. The patients
participated in psycho-educational groups about lithium
with a specialized nurse and support groups with psychi-
atrists to discuss topics related to the disease.
The patients who agreed to participate in the study gave
informed consent, were interviewed and had blood drawn
immediately for comparison between the concentrations
of lithium in the plasma with the LKT responses.
2.2. Variables
Demographical data
Every subject gave information about marital status, work,
age, gender and education level.
Current clinical status
Bipolar patients were diagnosed using the Structured Clin-
ical Interview for DSM-IV TR (SCID) and all patients were
followed up prospectively using mood charts.
LKT
LKT is a brief questionnaire to identify aspects of patients'
practical and pharmacological knowledge which are
important if therapy is to be safe and effective. The LKT
comprises 20 questions, which 1 point to be added for
every correct answer and 1 point to be deducted for every
wrong one. The correct answers are: 1-b; 2-b-c-f-h; 3-a-d-f;
4-a-b; 5-a-d; 6-c-e-f-g-i-k; 7-a-c-e. The total LKT score is
obtained by adding together the responses to the 20
points. The mean LKT scores were close to 6. The mean
LKT scores were > 6 indicating more knowledgeable. The
LKT Hazard comprises of 3, 4, 6 and 7 questions for rating
of identify aspects of intoxication symptoms about lith-
ium. The total LKT Hazard score was obtained by adding
together the responses to the 9 points. The mean LKT Haz-
ard score was close to 4 or more indicating more hazard.
The linguistic adaptation of the LKT started with docu-
ment in Portuguese obtained by a translation back trans-
lation method [17,18]. The items resulting in optimal
word equivalence with the original text were analysed by
the five of psychiatric investigators that agreed upon trans-
lation. Subsequently, bilingual people evaluated the
degree of equivalence between the English original and
the Portuguese version, as shown table 1. Finally, the
comprehension of each item was assessed with a sample
of 106 bipolar patients.
The LKT was administered on one occasion, when venous
blood to determine lithium concentration was collected
from each patient. The time to application of LKT was 10
minutes. We analysed the internal consistency, concurrent
validity in relation to plasma lithium concentration, sen-Clinical Practice and Epidemiology in Mental Health 2006, 2:34 http://www.cpementalhealth.com/content/2/1/34
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sitivity and specificity. Internal consistency was assessed
with Cronbach's Alpha for the total scale.
Concurrent validity was studied considering plasma lith-
ium concentration and the score obtained on the LKT by
means of Pearson's correlation.
To study the sensitivity, specificity and positive and nega-
tive values of the LKT, we calculated the proportion of
fully adherent bipolar patients by plasma lithium concen-
tration and the proportion of non-adherent bipolar
patients identified as such.
Lithium plasma concentration
The subjects were contacted seven days before the sched-
uled appointment and were instructed to be at the hospi-
tal early in the morning, without having taken their
lithium dose in the morning because the lithium blood
levels were to be measured, respecting a 12-hour interval
between the last dose of lithium and the blood sampling.
Venous blood was collected from each patient into Vacu-
tainer tube containing edetic acid. The whole blood was
then centrifuged 1600 × g for 10 minutes and the plasma
removed by aspiration. A 1/20 dilution in water was made
of 99 μl of plasma. Lithium concentrations were meas-
ured on the plasma dilutions by the indirect method,
using an Instrumentation Laboratory CELM Flame Pho-
tometer. Assays were performed in duplicate [19].
Statistical analysis
Statistical analysis was performed using SPSS for Win-
dows – Version 12.0 (SPSS Inc., Chicago, IL, USa). The
Kolmogorov-Smirnov test was used to compare an
observed cumulative distribution to a theoretical cumula-
tive distribution function. ANOVA test was used for com-
pare LKT scores and plasma levels of lithium. Pearson's
correlation coefficient was performed to examine the rela-
tionship between plasma lithium concentration and LKT
scores. The binomial variables (clinical state and LKT
scores) were compared using Chi-Square test. Validity was
assessed with Cronbach's alpha.
Results
The sample included 73 (68.9%) women, mean age 43.56
± 9.83 and 33 (31.1%) men with a mean age of 41.61 ±
9.72. At the time when the present study was carried out,
there were 77 (71.7%) euthymic, 12 (11.1%) manic and
17 (17.2%) depressed patients, according to the mood
charts and physician is assessment. Habits showed 40
(37.7%) were smokers, 70 (66%) used coffee on a regular
basis, and 68 (64.2%) had tea on a regular basis.
The answers to the LKT were obtained from 106 bipolar
patients and the mean score on the LKT was 9.0 ± 0.75 for
men and 8.74 ± 0.44 for woman and LKT HAZARD was
4.06 ± 0.19 for men and 3.96 ± 0.15 for woman. Table 2
describes the principal sociodemographic and clinical
characteristics of the study sample.
Table 1: Teste de Conhecimento do Lítio
Marque com um X as respostas que o Sr considerar correta.
1. Na sua opinião o LÍTIO age: (a) Como tranqüilizante; (b) Para prevenir mudanças de humor; (c) Como pílula para dormir; (d) Como tratamento 
para deficiência de LÍTIO
2. Quais os efeitos colaterais o LÍTIO pode causar? (a) Prisão de ventre (dificuldade de ir aos pés); (b) Mal-estar como enjôos; (c) Tremores; (d) 
Dor de cabeça; (e) Palpitações; (f) Urinar mais; (g) Insônia; (h) Aumento de peso
3. O que você deve tentar não fazer enquanto estiver tomando LÍTIO? (a) Suar excessivamente; (b) Tomar medicamento para tosse; (c) Climas 
muito frio; (d) Ficar grávida; (e) Fazer exercícios vigorosos; (f) Tomar diuréticos
4. Se você tivesse uma diarréia aguda e vômitos, o que você faria?(a) Ligaria para o seu médico; (b) Pararia de tomar LÍTIO imediatamente; (c) Iria 
para a cama e continuaria tomando LÍTIO regularmente; (d) Chamaria uma ambulância; (e) Aumentaria a dose de LÍTIO
5. Para que os exames de sangue regulares são necessários? (a) Para medir a quantidade de LÍTIO em seu sangue; (b) Para verificar se a doença é 
recorrente; (c) Para verificar se tem anemia; (d) Para testar o funcionamento da glândula tireóide
6. Quais das seguintes afirmações são verdadeiras?
(a) O LÍTIO deve ser tomado exatamente no mesmo horário todos os dias
(b) Deve-se tomar doses extras de LÍTIO se você se sente deprimido
(c) Não deve-se tomar LÍTIO pela manhã quando for fazer exame de sangue
(d) É normal não tomar algumas doses de LÍTIO se você se sente bem
(e) O LÍTIO não é eficaz se o nível sangüíneo estiver muito baixo
(f) O LÍTIO tem efeitos tóxicos se o nível sangüíneo estiver muito alto
(g) É comum o LÍTIO ser receitado por vários anos
(h) Parar de tomar o LÍTIO por completo geralmente leva a uma recaída
(i) O LÍTIO tem sido experimentado e testado por muitos anos
(j) O LÍTIO tem sido substituído por medicamentos modernos mais eficazes
(k) Uma recaída durante o tratamento com LÍTIO não prova que ele não seja eficaz para o indivíduo
7. Quando você estiver tomando LÍTIO, o que deveria evitar na sua alimentação? (a) Dieta para emagrecimento; (b) Comer queijo; (c) Reduzir o 
consumo de sal; (d) Comida vegetariana (e) Beber álcoolClinical Practice and Epidemiology in Mental Health 2006, 2:34 http://www.cpementalhealth.com/content/2/1/34
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The internal consistency coefficient obtained to 43 items
and the mean Cronbach's alpha of 0.596, for the total
scale indicating that the items are sufficiently homogene-
ous.
Concurrent validity based on diagnosis according to
plasma lithium concentration showed a significant corre-
lation between the total LKT score and plasma lithium lev-
els (r = 0.232; p = 0.020). The patients with higher LKT
scores are more likely to have plasma levels within the
therapeutic range.
We analysed the scale's discriminative capacity for bipolar
patients by means of the knowledge about lithium treat-
ment performance on sensitivity and specificity analysis.
The sensitivity was 84% and specificity was 81%.
There were no significant differences between the total
LKT scores among manic, depressive and euthymic
patients (Pearson Chi-Square < .05). Date not shown.
We analysed the frequency of positive/negative answers
on the LKT test by bipolar patients in comparison with
standard answers offered by the original scale, as shown in
table 3.
There was a significantly negative correlation between age
and LKT scores (r = -0.2; p = 0.04). Age was positively cor-
related with LKT HAZARD scores (r = 0.366; p = 0.001)
Discussion
Psychometric tests may be useful tools for the assessment
of bipolar patients, not only in research protocols, but
also in clinical practice [20]. LKT is a rapid, reliable instru-
ment which appears to be as effective as a lengthier stand-
ard interview with a lithium clinic doctor, and which has
a high level of acceptability to lithium patients. We found
that the psychometric assessment of the Portuguese ver-
sion of LKT showed good internal consistency, sensitivity
and specificity. In Brazilian bipolar patients, the Portu-
guese version of LKT showed total scores which were sim-
ilar of those described by Dharmendra et al. [21], in
Scottish bipolar patients (total scores 9.6). Indeed, there
was a significant negative correlation age and LKT scores
and a significant positive correlation between LKT and
Hazard scores, as shown in previous studies [21,22]. In
the convergent analysis the total LKT scores were signifi-
cantly correlated with plasma lithium levels, meaning
that, the patients with higher LKT scores were more likely
to have plasma levels within the therapeutic levels of lith-
ium. Moreover, sensitivity and specificity tests showed
good results, reinforcing the validation of Portuguese ver-
sion of the LKT.
The LKT scale asked bipolar patients about lithium phar-
macology aspects, such as, side effects, lithium interac-
tions, risks of intoxication, food and lithium, necessity of
measuring lithium levels, continuation of the lithium
dosages and others [23]. Our study indicated that Could
not you to do while you was taken lithium? Which of these
would be sensible actions if you developed acute diarrhoea and
vomiting? Why the regular blood tests are necessary? Lithium
must be taken at exactly the same times each day? Lithium is
not effective if the blood level falls too low? Stopping lithium
altogheter usually leads to a relapse? Which of the following
changes in diet can cause problems with lithium? were mainly
difficulties reported by bipolar patients, because of this
that patients with lower LKT scores are more uninformed
about intoxication risks.
The identification of problems about lithium treatment
and bipolar disorder with LKT could contribute to better
understanding of the difficulties that bipolar patients
have, and offer this specific information in the clinical
consultations. Indeed, knowledge about prescribed medi-
cation tends to be poor in the ederly and these patients
could have higher risks of intoxicacion with lithium than
younger patients. While it is possible that patients who
have been on lithium for a long time did not receive com-
prehensive information as did those who commenced
treatment more recently and they required some reeduca-
tion about lithium for some time [21].
Table 2: Demographics and clinical characteristics
Euthymic 71.7%
Manic 11.1%
Depressed 17.2%
Smokers 37.7%
Coffe 66%
Tea 64.2%
Men Women
31.1% 68.9%
Age 41,61 ± 9,72 43,56 ± 9,83
Mean total LKT 9,0 ± 0,75 8,74 ± 0,44
Mean LKT Hazard 4,06 ± 0,19 3,96 ± 0,15Clinical Practice and Epidemiology in Mental Health 2006, 2:34 http://www.cpementalhealth.com/content/2/1/34
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The knowledge level is a predictor of the adherence rates
in bipolar patients in according recent reported [9]. In
fact, Colom et al. [24] had reported that educated bipolar
patients showed lower relapses rates, lower number and
during hospitalizations. Psychoeducation is important to
definitely mean more than providing information to
patients and has shown its efficacy in stabilizing lithium
plasma levels by improving pharmacological treatment
adherence.
It is important to highlight several methodological issues.
First, as with any study of treatment adherence we are
hampered by the likelihood that the sample might have
included a representative sample. Such methodological
problems affect all studies in this field, as individuals who
are non- adherent with lithium are also likely to fail to
agree to participate or fail to adhere with research proto-
cols. Second, we did not assess current symptom severity
or comorbidity of bipolar disorder with other psychiatric
Table 3: Frequency of answers from TCL
Questions % true answer % false answer
1a 81.9 18.1
1b 64.8 35.2
1c 95.2 4.8
1d 77.1 22.9
2a 66.7 33.3
2b 41.9 58.1
2c 68.6 31.4
2d 61.9 38.1
2e 66.7 33.3
2f 67.6 32.4
2g 74.3 25.7
2h 83.8 16.2
53a 14.3 85.7
53b 91.4 8.6
53c 96.2 3.8
53d 43.8 56.2
53e 96.2 3.8
53f 37.1 62.9
54a 68.6 31.4
54b 12.4 87.6
54c 89.5 10.5
54d 93.3 6.7
54e 99.0 1.0
55a 89.5 10.5
55b 95.2 4.8
55c 96.2 3.8
55d 7.6 92.4
56a 20.0 80.0
56b 95.2 4.8
56c 82.9 17.1
56d 89.5 10.5
56e 52.4 47.6
56f 61.0 39.0
56g 79.0 21.0
56h 16.3 83.7
56i 75.2 24.8
56j 76.2 23.8
56k 73.3 26.7
57a 19.0 81.0
57b 89.5 10.5
57c 19.0 81.0
57d 95.2 4.8
57e 81.7 18.3Publish with BioMed Central    and   every 
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or physical disorders. Third, this was a cross-over study, as
we assessed knowledge about medication in only one
occasion. As yet, there is no research on the stability or
variability of such beliefs over time.
Conclusion
In conclusion, the LKT is a brief questionnaire to evaluate
the knowledge level in bipolar patients, identify aspects of
patients' practical and pharmacological knowledge which
are important if therapy is to be safe and effective. The LKT
scale may now be used in Portuguese speaking popula-
tions as a direct measure of knowledge on lithium as a
valid indirect measure of treatment adherence.
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